ReviewExpert review of hematology2018

Are BTK and PLCG2 mutations necessary and sufficient for ibrutinib resistance in chronic lymphocytic leukemia?

Benjamin L Lampson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.